Meet
Caroline Williams

Senior Associate

Caroline Williams supports clients with research and analysis that span a variety of healthcare sectors and stakeholders.

She applies her background in clinical and health outcomes research and management to a broad range of client projects.

Before joining Avalere, Caroline held a research position with The Cecil G. Sheps Center for Health Services Research at UNC-Chapel Hill where she conducted retrospective analyses on health services and demonstrated policy implications to stakeholders. Additionally, Caroline was an intern at PPD, Inc., a contract research organization, where she provided quality, data, and project management support for clinical trial studies.

Caroline has a BA in biology and economics from The University of North Carolina at Chapel Hill.

Authored Content


A dynamic regulatory landscape, technological advancements, and investments in R&D offer new opportunities and challenges in kidney care.

The industry should expect and prepare for changes to regulatory oversight of drug supply chains and quality.

Rare disease drug manufacturers can advance clinical development through FDA programs aimed at facilitating pipeline innovation.

Forty-four Part B drugs could be subject to new CMS wastage refund requirements according to an Avalere analysis of Medicare claims.